BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

Johnson & Johnson (JNJ) Opens Innovation Center In China for Medical Devices and Diagnostic Products


6/24/2011 9:35:38 AM

Johnson & Johnson Medical (Suzhou) Ltd announced it has established an innovation center in China to design and develop medical devices and diagnostic products specifically for Asia's emerging markets, primarily focusing on China and India. The Johnson & Johnson Medical Companies Asia Pacific Innovation Center located in Suzhou, China was officially opened today by Alex Gorsky, Vice Chairman of the Executive Committee, Johnson & Johnson. The Innovation Center is part of a Market Appropriate Innovation strategy aimed at better serving the people of Asia Pacific. Mr. Gorsky said 'Johnson & Johnson products touch around one billion people every day. The important question is how do we help the next billion, many of whom live in Asia where health care needs are intensifying?' Mr. Gorsky explained, 'Both China and India are experiencing an increase in the metabolic and chronic conditions such as cardiovascular disease, diabetes, obesity and cancer that many of our products diagnose or treat. With 125 years experience we believe Johnson & Johnson is uniquely positioned to help address the Asia's changing and growing health needs.'

Read at News Release
Read at ChinaBio Today

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES